Two San Francisco Startups, Element Science And Nurix, Reap Cash From Third Rock Ventures' Rich Funding Round

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Third Rock Ventures, an investment firm known for founding life sciences companies from scratch, made a big splash last year by raising $516 million for its third fund while many of its fellow venture capital firms were struggling. Since then, it’s been putting that new money to work. Over the past three months, Third Rock’s original Boston office formed two Cambridge, MA-based companies, Voyager Therapeutics and Editas Medicine. And now, the firm’s newer San Francisco office, launched in 2010, is about to unveil financing deals for two San Francisco-based startups, cardiac device company Element Science and cancer drug discovery company Nurix—adding to the eight companies already nurtured by Third Rock’s West Coast branch.

Help employers find you! Check out all the jobs and post your resume.

Back to news